newsfilter
← Latest News
Business Wire·

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

Believes Transaction Significantly Undervalues Quanterix Highlights that Quanterix's Board is Essentially Rescuing Akoya at the Direct Expense of Quanterix Shareholders Transaction Would Introduce Unnecessary Risk and